A maintenance plan may include: Continued follow-up visits Adjusted medication strategy Protein and resistance-training goals Monitoring weight trends before regain becomes significant Revisiting sleep, stress, alcohol, and nutrition habits Lab monitoring when appropriate A plan for travel, holidays, plateaus, and life disruptions Long-term success depends on building a system that can be maintained in real life
GLP-1 agonists which include semaglutide medications such as Wegovy and Ozempic are a class of medications that mimic the GLP-1 hormone to help treat diabetes and obesity
Despite high hopes that new agents will soon be added to the few available drugs for the treatment of NASH, antidiabetic agents remain the sole alternative, apart from vitamin E, offering a multi-target and relatively effective approach to the treatment of patients with both NAFLD/NASH and DM2
Choosing the right next-gen weight loss medication is a decision that requires expert guidance, integrating the latest clinical data with your unique health history, cardiovascular profile, and longevity goals